As of 2025-05-29, the Gross Margin of Chongqing Lummy Pharmaceutical Co Ltd (300006.SZ) is 63.3%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 63.3% |
2023-12-31 | 68.9% |
2022-12-31 | 73.3% |
2021-12-31 | 69.2% |
2020-12-31 | 66.9% |
2019-12-31 | 71% |
2018-12-31 | 60.5% |
2017-12-31 | 48.6% |
2016-12-31 | 41.1% |
2015-12-31 | 36.6% |